By Jonathan Randles ( May 3, 2016, 5:22 PM EDT) -- Investors who accuse KaloBios Pharmaceuticals Inc. of concealing criminal investigations into former CEO Martin Shkreli are in line to receive a cut of any proceeds the company gets in a potential lawsuit against the bankrupt drugmaker's former outside counsel Kaye Scholer LLP, according to a settlement filed Monday in Delaware....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.